Realcan Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 002589.SZ

Realcan Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 1.25

Realcan Pharmaceutical Group Co., Ltd. Debt to Equity Ratio is 1.25 for the year ending December 31, 2023, a 72.89% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Realcan Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.72, a 28.42% change year over year.
  • Realcan Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.56, a -55.75% change year over year.
  • Realcan Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 1.28, a 39.38% change year over year.
  • Realcan Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.91, a 1.48% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
Shenzhen Stock Exchange: 002589.SZ

Realcan Pharmaceutical Group Co., Ltd.

CEO Mr. Xu Han
IPO Date June 10, 2011
Location China
Headquarters No. 326, Airport Road
Employees 3,239
Sector Health Care
Industries
Pharmaceuticals Drugstores & Retail Pharmacies Medical Instruments
Description

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.

Similar companies

002422.SZ

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 3.88

-0.13%

002508.SZ

Hangzhou Robam Appliances Co., Ltd.

USD 2.88

0.19%

002424.SZ

Guizhou Bailing Group Pharmaceutical Co., Ltd.

USD 0.54

1.47%

002583.SZ

Hytera Communications Corporation Limited

USD 1.70

-6.17%

002491.SZ

Tongding Interconnection Information Co., Ltd.

USD 0.63

-7.40%

StockViz Staff

January 31, 2025

Any question? Send us an email